INCREASED LIVER STIFFNESS IN ALCOHOLIC LIVER DISEASE: DISSECTING FIBROSIS FROM STEATOHEPATITIS

被引：1
|
作者：
Mueller, S. [1 ,2 ]
Millonig, G. [1 ,2 ]
Friedrich, S. [1 ,2 ]
Stickel, F. [3 ]
Longerich, T. [4 ]
Schirmacher, P. [4 ]
Seitz, H. -K. [1 ,2 ]
机构：
[1] Univ Heidelberg, Alcohol Res Ctr, Heidelberg, Germany
[2] Univ Heidelberg, Salem Med Ctr, Heidelberg, Germany
[3] Univ Bern, Bern, Switzerland
[4] Univ Heidelberg, Inst Pathol, D-6900 Heidelberg, Germany
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)60415-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S169 / S169
页数：1
相关论文
共 50 条
  • [31] Liver stiffness measurement to platelet ratio index predicts the stage of liver fibrosis in non-alcoholic fatty liver disease
    Okajima, Akira
    Sumida, Yoshio
    Taketani, Hiroyoshi
    Hara, Tasuku
    Seko, Yuya
    Ishiba, Hiroshi
    Nishimura, Takeshi
    Umemura, Atsushi
    Nishikawa, Taichiro
    Yamaguchi, Kanji
    Moriguchi, Michihisa
    Mitsuyoshi, Hironori
    Yasui, Kohichiroh
    Minami, Masahito
    Itoh, Yoshito
    HEPATOLOGY RESEARCH, 2017, 47 (08) : 721 - 730
  • [32] Non-alcoholic fatty liver disease and steatohepatitis
    Par Gabriella
    Horvath Gabor
    Par Alajos
    ORVOSI HETILAP, 2013, 154 (29) : 1124 - 1134
  • [33] Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
    Tacke, Frank
    Weiskirchen, Ralf
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [34] PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE, HIGH-RISK NON-ALCOHOLIC STEATOHEPATITIS, AND LIVER FIBROSIS IN PATIENTS WITH OSTEOARTHRITIS
    Kalligeros, Markos
    Vassilopoulos, Athanasios
    Vassilopoulos, Stephanos
    Wands, Jack R.
    Promrat, Kittichai
    HEPATOLOGY, 2023, 78 : S1034 - S1035
  • [35] A model to identify patients at increased risk of liver fibrosis in non-alcoholic fatty liver disease
    Hannah, N.
    Kemp, W.
    Majeed, A.
    Roberts, S. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 94 - 95
  • [36] Dissecting the role of cadmium, lead, arsenic, and mercury in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Tinkov, Alexey A.
    Aschner, Michael
    Santamaria, Abel
    Bogdanov, Alfred R.
    Tizabi, Yousef
    Virgolini, Miriam B.
    Zhou, Ji-Chang
    V. Skalny, Anatoly
    ENVIRONMENTAL RESEARCH, 2023, 238
  • [37] The role of elastography for liver fibrosis screening in alcoholic liver disease
    Foncea, Camelia Gianina
    Moga, Tudor Voicu
    Sporea, Ioan
    Popa, Alexandru
    Sirli, Roxana
    Bende, Felix
    Popescu, Alina
    Fofiu, Renata
    MEDICAL ULTRASONOGRAPHY, 2022, 24 (04) : 406 - 413
  • [38] The utility of the enhanced liver fibrosis test in alcoholic liver disease
    Connoley, Declan
    Patel, Preya
    Hogan, Brian
    Tanwar, Sudeep
    Rhodes, Freya
    Parkes, Julie
    Sievert, William
    Rosenberg, William
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E815 - E815
  • [39] NASH (Non-Alcoholic Steatohepatitis): Fatty Liver or Fatal Liver Disease?
    Roeb, E.
    ZENTRALBLATT FUR CHIRURGIE, 2014, 139 (02): : 168 - 174
  • [40] Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis
    Sanchez-Jimenez, Beatriz A.
    Brizuela-Alcantara, Diana
    Ramos-Ostos, Martha H.
    Alva-Lopez, Luis F.
    Uribe-Esquivel, Misael
    Chavez-Tapia, Norberto C.
    ALCOHOL, 2018, 69 : 63 - 67
12345